Somatus, a value-based kidney care company, has acquired strategic assets from Lumiata, a healthcare-specific AI platform, reports Healthcare Innovation. Somatus said it would leverage Lumiata’s ability to accurately predict high-cost claimants and likelihood of disease progression, advancing its capability to reduce costs for providers and health plans.
McLean, Va.-based Somatus recently announced a Series E financing round of more than $325 million. Read more.
